Business and Innovation

Is artificial intelligence tomorrow’s answer to screening, management, and treatment? Experts weigh in.

With a growing armamentarium for glaucoma, balancing safety and efficacy is the modern-day challenge

Introducing the new Worldwide President, Surgical, at Johnson & Johnson Vision… Warren Foust

A round-up of novel coronavirus-related stories

The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning

Organ-to-cloud technology is here – and it has its sights set on glaucoma

The standard of care for wet AMD presents a big burden for patients, so what other options are out there?

Four deep learning experts discuss the ethical implications of using advanced technologies in eye care – and potential solutions

A round-up of this month’s acquisitions, approvals and the beginning of Ophthovation…

Virtual reality is adding a new dimension to education for common ocular diseases